These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25532865)

  • 1. Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis.
    Bhattacharyya S; Atakan Z; Martin-Santos R; Crippa JA; Kambeitz J; Malhi S; Giampietro V; Williams S; Brammer M; Rubia K; Collier DA; McGuire PK
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):26-37. PubMed ID: 25532865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
    Bhattacharyya S; Fusar-Poli P; Borgwardt S; Martin-Santos R; Nosarti C; O'Carroll C; Allen P; Seal ML; Fletcher PC; Crippa JA; Giampietro V; Mechelli A; Atakan Z; McGuire P
    Arch Gen Psychiatry; 2009 Apr; 66(4):442-51. PubMed ID: 19349314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC.
    Bhattacharyya S; Sainsbury T; Allen P; Nosarti C; Atakan Z; Giampietro V; Brammer M; McGuire PK
    Psychol Med; 2018 Dec; 48(16):2748-2756. PubMed ID: 29502548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition.
    Borgwardt SJ; Allen P; Bhattacharyya S; Fusar-Poli P; Crippa JA; Seal ML; Fraccaro V; Atakan Z; Martin-Santos R; O'Carroll C; Rubia K; McGuire PK
    Biol Psychiatry; 2008 Dec; 64(11):966-73. PubMed ID: 18589404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.
    Bhattacharyya S; Crippa JA; Allen P; Martin-Santos R; Borgwardt S; Fusar-Poli P; Rubia K; Kambeitz J; O'Carroll C; Seal ML; Giampietro V; Brammer M; Zuardi AW; Atakan Z; McGuire PK
    Arch Gen Psychiatry; 2012 Jan; 69(1):27-36. PubMed ID: 22213786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing.
    Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
    Exp Clin Psychopharmacol; 2018 Dec; 26(6):582-598. PubMed ID: 30138003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.
    Atakan Z; Bhattacharyya S; Allen P; Martín-Santos R; Crippa JA; Borgwardt SJ; Fusar-Poli P; Seal M; Sallis H; Stahl D; Zuardi AW; Rubia K; McGuire P
    Psychol Med; 2013 Jun; 43(6):1255-67. PubMed ID: 23020923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
    Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
    Winton-Brown TT; Allen P; Bhattacharyya S; Borgwardt SJ; Fusar-Poli P; Crippa JA; Seal ML; Martin-Santos R; Ffytche D; Zuardi AW; Atakan Z; McGuire PK
    Neuropsychopharmacology; 2011 Jun; 36(7):1340-8. PubMed ID: 21412224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.
    Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV
    Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans.
    Cortes-Briones JA; Cahill JD; Skosnik PD; Mathalon DH; Williams A; Sewell RA; Roach BJ; Ford JM; Ranganathan M; D'Souza DC
    Biol Psychiatry; 2015 Dec; 78(11):805-13. PubMed ID: 25913109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
    D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J
    Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control.
    Bhattacharyya S; Iyegbe C; Atakan Z; Martin-Santos R; Crippa JA; Xu X; Williams S; Brammer M; Rubia K; Prata D; Collier DA; McGuire PK
    Psychol Med; 2014 Nov; 44(15):3315-28. PubMed ID: 25065544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of oral cannabis and dronabinol on driving capacity].
    Giroud C; Augsburger M; Favrat B; Menetrey A; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mathieu S; Castella V; Hazekamp A; Mangin P
    Ann Pharm Fr; 2006 May; 64(3):161-72. PubMed ID: 16710114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.
    Hindley G; Beck K; Borgan F; Ginestet CE; McCutcheon R; Kleinloog D; Ganesh S; Radhakrishnan R; D'Souza DC; Howes OD
    Lancet Psychiatry; 2020 Apr; 7(4):344-353. PubMed ID: 32197092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
    Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
    Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Acute Δ
    Bloomfield MAP; Petrilli K; Lees R; Hindocha C; Beck K; Turner RJ; Onwordi EC; Rane N; Lythgoe DJ; Stone JM; Curran HV; Howes OD; Freeman TP
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):660-667. PubMed ID: 34099186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness.
    Koethe D; Gerth CW; Neatby MA; Haensel A; Thies M; Schneider U; Emrich HM; Klosterkötter J; Schultze-Lutter F; Leweke FM
    Schizophr Res; 2006 Dec; 88(1-3):142-50. PubMed ID: 17005373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis.
    Colizzi M; Weltens N; McGuire P; Lythgoe D; Williams S; Van Oudenhove L; Bhattacharyya S
    Mol Psychiatry; 2020 Dec; 25(12):3231-3240. PubMed ID: 30770892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.